Illustrative

FDA Approves Eli Lilly’s New Weight Loss Pill Foundayo

TODAY.com·Apr 2

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved a new weight loss pill called Foundayo, developed by Eli Lilly. The pill is a GLP-1 type medication, and its approval is seen as a development in the weight loss drug market, providing another option for patients. Foundayo is described as a once-daily medication, and its approval has been granted in a speedy manner.

Full coverage

FDA approves Eli Lilly’s weight-loss pill; Judge revokes citizenship over stolen medical secrets for China; new COVID-19 ‘Cicada’ variant spreads to 25 states – Morning Medical Update

Medical Economics·20h ago

FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly

NBC News·Apr 1

F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo - The New York Times

The New York Times·Apr 1

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

CNBC·Apr 1

The FDA approves a new obesity pill, giving patients another option

NPR·Apr 1

FDA Approves Eli Lilly's Obesity Pill, Foundayo

Time Magazine·Apr 2

Explainer: What to Know About Foundayo, Eli Lilly’s New Once-Daily Weight-Loss Pill

U.S. News & World Report·Apr 2

FDA grants speedy approval to Eli Lilly weight-loss pill

The Hill·Apr 1

View original report at TODAY.com ↗

Fetching the latest headlines…